Navigation Links
Spheris Reports Fourth Quarter and Year-End 2007 Results
Date:3/26/2008

measure of the performance of the Company's operations because it isolates the Company's operating performance from the accounting impact of the Company's financing strategies, tax provisions, and depreciation and amortization. Additionally, since EBITDA is a significant component of certain financial covenants under the Company's senior secured credit facility agreement, management believes EBITDA is useful for investors to better assess the Company's compliance with these financial covenants. Management believes EBITDA should be considered in addition to, but not as a substitute for, items prepared in accordance with GAAP that are presented in this press release, as the items excluded in the presentation of EBITDA are significant components in understanding and assessing financial performance. A reconciliation of EBITDA to the nearest comparable GAAP financial measure is provided above. EBITDA, as presented, may not be comparable to similarly titled measures of other companies.


'/>"/>
SOURCE Spheris
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
2. Spheris Elects New Board Member
3. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
4. QMed, Inc. Reports Year-End and Fourth Quarter Results
5. Pelosi Statement on Social Security and Medicare Trustees Reports
6. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports
7. SPO Medical Reports 2007 Sales: Growth of 35% Compared to 2006
8. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
9. U.S. Army Study Reports WoundStat(TM) is Most Effective
10. CryoCor Reports 2007 Results
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...ical ceramic company strengthens global team , ,... a subsidiary of the largest manufacturer of techn...at Dr. Steven Hughes has joined the company as Sal... , Steven will spearhead the business developmen...erks in Europe and Latin America in addition to su...
(Date:1/7/2009)...TLETON, Colo., Jan. 7 Zuma,s Rescu...month wait, and three years of being self funded, ...nations and sponsorship! , , Zuma,s Rescue Ran...ing a non-profit charity we have been working with...o cover Equine Assisted Psychotherapy for foster c...
(Date:1/7/2009)...ochelle, NY, January 6, 2009Dedicated to the memor...man, who pioneered the fields of angiogenesis and ...blood supply and neoplastic disease, the newly rel...of Lymphatic Research and Biology includes a ser...one of the pre-eminent physician-scientists of his...
(Date:1/7/2009)...BIA, Mo. There is no cure for spinal muscular atr...kening of muscles and is the leading genetic cause...rchers have discovered a new therapeutic target th...aused by SMA. The new therapy enhanced muscle stre...e lifespan in a SMA model. , "This therapy doe...
Breaking Medicine News(10 mins):Health News:Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks 2Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2
...h as it induces lot of alterations in the metaboli...s the risk of colorectal tumours, while drinking i.... // The study was conducted by Joseph C. Anders...Stony Brook University, Stony Brook, New York. 2,...
...e of Tropical Medicine has published the results o... said that the HIV virus has become less pathogeni...more sensitive to anti-retroviral drugs compared t...ch team compared the HIV samples collected in betw...
...ps to provide protection against lung cancer, acco...e believed to be responsible are plant-derived com...ts, grains, carrots, spinach, broccoli and other f...e University of Texas M.D. Anderson Cancer Center ...
...s lies at hand but that is the place no one looks....A weight control protein with a key role in the br...d new approaches for treating obesity and type 2 d... suggest that particular variants of the protein S...
Other Medicine News:Health News:Alcohol Consumption A Threat To Colorectal Tumours 2Health News:An Answer To Obesity: Weight Control Protein 2
(Date:1/7/2009)...ucts in Development Based On Osteotech,s Proprieta...BioRegeneration; FDA Filing Anticipated in Third Q...swire-FirstCall/ -- Osteotech, Inc. (Nasdaq: O...products for regenerative healing, announced today...r its DuraTech(TM) BioRegeneration Matrix. The fir...
(Date:1/6/2009)... In recent controlled studies cond...is , scientists found that the patented ingredient...only proven ingredient to increase levels of nitri... nitrate/nitrate (NOx) in human subjects. , , N...ncrease in blood flow to the skeletal muscles. Th...
(Date:1/6/2009)...nuary 6 , - Early...ion Until,December 2011 , - Expansion of t...,Discovery in Ophthalmology , - Revised Com...,Sublicenses to a Third Party , ExonHit T...einforcement,of its existing drug discovery colla...
(Date:12/30/2008)...PRNewswire-USNewswire/ -- The Coalition for 21st C...ion filed by Genentech, Inc. on December 5, 2008, ... offer diagnostic tests to physicians and patients...tests, would harm patient care and rests on flawed...on,s mission is to encourage the research, develop...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4UNC researchers find MSG use linked to obesity 4457 1UNC researchers find MSG use linked to obesity 4457 2Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results 25405 1Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results 25405 2Orbis Education Expands Nursing Education Program to Glendale California 25403 1Orbis Education Expands Nursing Education Program to Glendale California 25403 2Orbis Education Expands Nursing Education Program to Glendale California 25403 3Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 1Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 2Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 3Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 4
...007 /PRNewswire-FirstCall/ -- Boston,Scientific Co...icle,in the Journal of of Cardiology (JACC) review...s the Company,s second-generation,TAXUS(R) Liberte...le in the April 24 edition of JACC concluded that ...of the TAXUS Liberte Stent,system compared to the ...
...ta Presented at ASCO -, CHICAGO, June 04, 2007 /PR...y that Soliris(TM) (eculizumab), a new treatment f...oped by Alexion,Pharmaceuticals, Inc. , is effecti...ry of aplastic anemia (AA) or myelodysplastic,synd...od cell,destruction (hemolysis), decreased or elim...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
...to / MVR knife. 1.1 mm (19G) with a 1.38 mm width ...ca). State-of-the-art manufacturing and quality co...d precise. Sure grip handles have a ridge indicati... fluid tight incision for self-sealing wounds. Gau...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Renu Multiplus preservative free lubricating and rewetting drops soothe and moisturize your eyes while you're wearing soft contact lenses. The gentle preservative free formula is ideal for eyes that
Medicine Products: